Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 48

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 48
---
(7)                                                       |     |              |     | 1,285,017 |     |              |  3.6 | % |
| Laurie B. Keating(8)                                                    |     |              |     |   151,874 |     |              |      | * |
| Diana F. Hausman, MD(9)                                                 |     |              |     |    82,235 |     |              |      | * |
| Thomas J. Schall, Ph.D.(10)                                             |     |              |     |    26,071 |     |              |      | * |
| All current executive officers and directors as a group(13 persons)(11) |     |              |     | 8,930,645 |     |              | 22.9 | % |

_____________

* Represents beneficial ownership of less than 1%.

(1) Based solely on a Schedule 13G/A filed with the SEC on March 27, 2024. Merrin Investors LLC has sole voting and sole dispositive power over 2,770,386 of our Class A common stock. Seth Merrin is the managing member of Merrin Investors LLC and as such shares voting and dispositive power over the securities held of record by Merrin Investors LLC. The address for Merrin Investors LLC is 2547 Maple Avenue, Cortlandt Manor, NY 10567.

(2) Consists of (i) 2,281,852 shares of our Class A common stock, (ii) 919,415 shares of our Class A common stock underlying options exercisable within 60 days from April 17, 2025, and (iii) 894,927 shares of our Class A common stock held of record by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind’s spouse, serves as sole trustee and may be deemed to have sole voting and dispositive power with respect to the shares held of record by the Benjamin J. Zeskind 2020 Family Trust. Dr. Zeskind may be deemed to have beneficial ownership with respect to such shares.

(3) Consists of (i) 3,850 shares of our Class A common stock and (ii) 270,201 shares of our Class A common stock underlying options exercisable within 60 days from April 17, 2025.

<div align='center'>32</div>

TABLE OF CONTENTS

(4)